Furthermore, previous studies in bladder and pancreatic cancer, tumors for which we did not find links to unfavorable tumor features, have provided inconsistent results, either suggesting [66–68] or rejecting [19, 69, 70] a prognostic role of reduced E-Cadherin expression. This evidence concerns the gene CDH1 and familial pancreatic carcinoma.